| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| enVVeno Medical Corp | SVP & Chief Medical Officer | Common Stock | 1,600 | $544 | $0.3400 | 16 Dec 2025 | Direct |
| enVVeno Medical Corp | SVP & Chief Medical Officer | Stock Options | 75,000 | 18 Dec 2024 | Direct | ||
| enVVeno Medical Corp | SVP & Chief Medical Officer | Restricted Stock Units | 0 | 16 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | 16 Dec 2025 | 1 | $0 | 4 | SVP & Chief Medical Officer | 18 Dec 2025, 17:47 |
| NVNO | enVVeno Medical Corp | 18 Dec 2024 | 1 | $0 | 4 | SVP & Chief Medical Officer | 20 Dec 2024, 20:33 |
| NVNO | enVVeno Medical Corp | 05 Dec 2023 | 1 | $0 | 4 | SVP & Chief Medical Officer | 07 Dec 2023, 17:05 |
| NVNO | enVVeno Medical Corp | 30 Nov 2021 | 2 | $0 | 4 | SVP & Chief Medical Officer | 02 Dec 2021, 17:26 |
| NVNO | Hancock Jaffe Laboratories, Inc. | 21 May 2021 | 1 | +$9,440 | 4 | SVP & Chief Medical Officer | 25 May 2021, 17:15 |